Explore the case study and see how polymer science is shaping the future of drug development: USP Case Study Lupron Depot #USP #PolymerScience #DrugDevelopment #PharmaceuticalInnovation #LupronDepot #PLGA #Biopharma #QualityStandards #RegulatoryCompliance #LongActingInjectables To view or add a comment, sign in Poly(N-isopropylacrylamide) (PNIPAM) Consider how PNIPAM transforms a raw active ingredient into a stable, injectable formulation that releases drug precisely when needed
GHKCu helps stimulate collagen and elastin production, improving skin firmness, elasticity, and overall appearance
WADA Prohibited List (2025), Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics (Insulin-like Growth Factor-1 and its analogues)
GLP-1 side effects (nausea, vomiting, constipation) are generally well-tolerated and diminish over time
New England Journal of Medicine , 382(13), 1244-1256
Methods ReCePI is a prospective, multicenter, randomized, double-blinded, active-controlled, parallel-design, non-inferiority study